145 related articles for article (PubMed ID: 36898672)
1. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
Masset Z; Gunaratnam S; Millette M; McFarland LV; Lacroix M
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36898672
[TBL] [Abstract][Full Text] [Related]
2. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Auclair J; Frappier M; Millette M
Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
[TBL] [Abstract][Full Text] [Related]
4. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Maziade PJ; Pereira P; Goldstein EJ
Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
McFarland LV; Ship N; Auclair J; Millette M
J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
[TBL] [Abstract][Full Text] [Related]
6. Probiotics and prevention of Clostridium difficile infection.
Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
[TBL] [Abstract][Full Text] [Related]
7. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Bio-K+ for the prevention of
Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
[TBL] [Abstract][Full Text] [Related]
9. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Gao XW; Mubasher M; Fang CY; Reifer C; Miller LE
Am J Gastroenterol; 2010 Jul; 105(7):1636-41. PubMed ID: 20145608
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Maziade PJ; Ship N; Sniffen JC; Goldstein EJC
Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076
[TBL] [Abstract][Full Text] [Related]
11. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
Lahtinen SJ; Forssten S; Aakko J; Granlund L; Rautonen N; Salminen S; Viitanen M; Ouwehand AC
Age (Dordr); 2012 Feb; 34(1):133-43. PubMed ID: 21264685
[TBL] [Abstract][Full Text] [Related]
12. Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
Aroutcheva A; Auclair J; Frappier M; Millette M; Lolans K; de Montigny D; Carrière S; Sokalski S; Trick WE; Weinstein RA
Probiotics Antimicrob Proteins; 2016 Mar; 8(1):31-40. PubMed ID: 26915093
[TBL] [Abstract][Full Text] [Related]
13. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
Maziade PJ; Andriessen JA; Pereira P; Currie B; Goldstein EJ
Curr Med Res Opin; 2013 Oct; 29(10):1341-7. PubMed ID: 23931498
[TBL] [Abstract][Full Text] [Related]
14. Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems.
Gunaratnam S; Millette M; McFarland LV; DuPont HL; Lacroix M
Microb Pathog; 2021 Apr; 153():104798. PubMed ID: 33609647
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis.
Pattani R; Palda VA; Hwang SW; Shah PS
Open Med; 2013; 7(2):e56-67. PubMed ID: 24348885
[TBL] [Abstract][Full Text] [Related]
16. In-vitro determination of inhibitory effects of probiotic strains on Clostridioides difficile.
Yalçin GT; Tosun MN; Demirel Zorba NN
Anaerobe; 2023 Jun; 81():102737. PubMed ID: 37217116
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms and safety of probiotics against toxigenic
Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
[TBL] [Abstract][Full Text] [Related]
19. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
[TBL] [Abstract][Full Text] [Related]
20. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
McFarland LV; Johnson SB; Evans CT
Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
